Abstract: The new pharamaceutical composition (PTC) and process are provided for treating and preventing cardiovascular disease.The fine-PTC is composed of following ingredients: Puerarin or derivate of Puerarin; Danshensu or Danshenketone; Tetramethyl pyrazine; Polysaccharides and Ssponin of Dangshen.The composition is nontoxic.